SOPs for Analytical Method Development V 2.0

This SOP defines the procedure to evaluate the compatibility of various filter membranes used for sample withdrawal during dissolution testing. It ensures that filters do not adsorb the drug or alter the sample composition, thereby maintaining data accuracy and integrity.
Click to read the full article.

This SOP outlines the step-by-step procedure for developing dissolution methods specifically for floating or swelling dosage forms. These formulations require unique testing conditions to address buoyancy, retention, and hydration behavior during drug release studies.
Click to read the full article.

This SOP outlines the method development process for Preservative Efficacy Testing (PET), also known as antimicrobial effectiveness testing. The goal is to ensure the formulation’s preservative system inhibits microbial growth effectively throughout its intended shelf life.
Click to read the full article.

This SOP outlines the standardized procedure for identifying bacteria and fungi using biochemical testing techniques, including the use of commercial identification kits and confirmatory manual tests, for characterization of microbial isolates from pharmaceutical environments or product samples.
Click to read the full article.

This SOP defines the procedure for performing the Bacterial Endotoxin Test (BET) using the kinetic-turbidimetric Limulus Amebocyte Lysate (LAL) method. This method enables quantitative detection of endotoxins in pharmaceutical substances and products.
Click to read the full article.

This SOP outlines the procedure for utilizing environmental microbial isolates obtained from pharmaceutical cleanroom or production areas in challenge studies for preservative efficacy testing, disinfectant validation, and cleaning method assessment.
Click to read the full article.

This SOP outlines the procedure for developing and validating bioburden testing methods for Active Pharmaceutical Ingredients (APIs), ensuring appropriate microbial enumeration and absence of specified organisms according to pharmacopeial standards.
Click to read the full article.

This SOP provides a systematic approach for developing antimicrobial activity testing methods for raw materials and pharmaceutical products using standard microbiological techniques including agar diffusion, broth dilution, and minimal inhibitory concentration (MIC) determinations.
Click to read the full article.

This SOP describes the procedure for conducting method suitability tests to verify that non-sterile pharmaceutical products do not inhibit microbial recovery, ensuring the validity of microbial enumeration and specified organism tests.
Click to read the full article.

This SOP defines the procedure for detecting, isolating, and identifying objectionable microorganisms in non-sterile pharmaceutical products to ensure patient safety, regulatory compliance, and product quality based on the nature and route of administration.
Click to read the full article.